NKTX

Conviction 66HealthcareScan · Thu, Jun 25, 2026

NKTX$2.79-3.46%

ResistanceSupportVol 14Insider sell

Vol MA14 607.13K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Nkarta, Inc.PHARMACEUTICAL PREPARATIONSwww.nkartatx.com ↗

Price2.79

Change-3.46%

Gap+3.11%

Rel volume0.65×

Avg volume543.52K

Avg $ vol1.52M

SMA 202.79

SMA 502.91

SMA 2002.31

Price vs 50-4.17%

Price vs 200+20.57%

MA stackmixed

50/200 cross—

Supertrenddown · 3.05

RSI (14)49

MACD hist0.02

MACD crossbull · 3d

Stoch %K / %D55 / 68

ADX (14)17

+DI / −DI25 / 18

RSI divergence—

MACD divergence—

ATR %+8.58%

ADR %8.29%

52w high3.49

52w low1.66

From 52w high-20.06%

Above 52w low+68.07%

New 52w highNo

SqueezeOff

Bollinger width35.07%

%B0.50

Donchian pos47.24%

Donchian high3.32

Donchian low2.32

AVWAP (52w high)2.94

vs AVWAP high-5.17%

AVWAP (52w low)2.31

vs AVWAP low+20.52%

OBV trendFlat

Chaikin MF (20)-0.13

Today vs 20d0.65×

Avg vol (14d)607.13K

Avg vol (20d)543.52K

Avg $ vol (20d)1.52M

Market cap199.61M

RS 3m (vs SPY)+28.72%

RS 6m (vs SPY)+53.72%

RS line new highNo

Trend template7/8

Technical rank64.8

1 week+5.68%

1 month-8.82%

3 months+30.99%

6 months+55.00%

1 year+59.43%

YTD+49.20%

P/E-1.92

P/B0.70

P/S—

P/FCF-2.22

EPS-1.41

Div yield—

ROE-36.41%

ROA-27.97%

Debt/Eq—

Current12.96

EV/EBITDA-1.53

Gross margin—

Net margin—

Rev growth—

EPS growth4.33%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value172.26M

Revenue2.31K

Net income-27.83M

Gross profit—

Free cash flow-89.91M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out71.55M

Employees108

ListedFri, Jul 10, 2020

Free float43.75M

Float %61.6%

Short interest5.23M

Days to cover10.2d

Short volume41.1%

Squeeze score50 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction66 / 100

Pattern quality—

Tech rank64.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.34

Support2.45

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NKTX

All disclosures →

No recent disclosed trades by Congress in NKTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NKTX · 1 sell

Insider	Side	Shares	Value	Traded	Filed
HASTINGS PAUL J Chief Executive Officer · Common Stock · 2026-06-18	Sell	1.78K	$5K	2026-06-18	2026-06-22

SEC filings

EDGAR filings in NKTX · 1 recent

EDGAR →

8-K8-KThu, Jun 11, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.